Loading…
This event has ended. Create your own event on Sched.
This virtual series will start at 11AM EDT each day and features four themes - Operational Excellence, Marketing, Regulatory Compliance, and Legal Considerations. Attend the sessions that fit your needs, get your questions answered, and further the conversations important to you.

Be sure to REGISTER TODAY and secure your seat at this free virtual event!

Sign up or log in to bookmark your favorites and sync them to your phone or calendar.

Life Sciences [clear filter]
Monday, August 10
 

10:00am EDT

10:05am EDT

Keynote: The Future Value of AI
  • Ideas to consider         
  • Questions to ask         
  • Architectural approaches         
  • Buy-in from the board         
  • Connecting the dots inside a company         
  • Real-world applications

Speakers
avatar for Bob Evans

Bob Evans

Founder & CEO, Evans Strategic Communications LLC, Cloud Wars Media LLC
Bob Evans is one of the world’s leading analysts of the technology industry and the global phenomenon of digital transformation. In 2012, he was recruited by Oracle founder Larry Ellison to be the company’s first chief communications officer, and he left there after 5 years to... Read More →


Monday August 10, 2020 10:05am - 10:30am EDT
TBA

11:00am EDT

Life Sciences Track - High-Tech Pandemic: How Researchers Are Using AI to Track Down Potential COVID-19 Treatments
Epidemiologists have drawn some parallels between the 1918 flu pandemic and today’s COVID-19 crisis. But today’s disease-fighters have powerful AI tools scientists in the early 20th century could never have imagined. Researchers are using AI to design virus-blocking proteins. Others are using a suite of tools to simultaneously expose the virus’ vulnerabilities and discover drugs that could exploit them. In fact, AI engines have already screened billions of molecules in their hunt for prospective treatments and vaccines. We’ll explore the possibilities—and the progress so far—with experts who are taking AI to the coronavirus fight.

Moderators
avatar for Conor Hale

Conor Hale

Associate Editor, Fierce Biotech
Conor Hale is an associate editor writing for FierceMedTech and FierceBiotech. He has previously covered the pharmaceutical and medical research industries in the Washington, D.C., area for The Cancer Letter and FDAnews. Conor graduated from St. Bonaventure University’s journalism... Read More →

Speakers
avatar for Alex Zhavoronkov, Ph.D.

Alex Zhavoronkov, Ph.D.

Founder & CEO, Insilico
Prof. Zhavoronkov is the Founder and CEO of Insilico Medicine, a leader in the next-generation AI for drug discovery, biomarker development, and aging research. Prior to Insilico, he worked in senior roles at ATI Technologies, NeuroG Neuroinformatics, the Biogerontology Research... Read More →
avatar for Peter Richardson

Peter Richardson

Vice President of Pharmacology, BenevolentAI
avatar for Arvind Ramanathan

Arvind Ramanathan

Technology Leader, Argonne National Laboratory
Arvind Ramanathan is a computational biologist in the Data Science and Learning Division at Argonne National Laboratory and a senior scientist at the University of Chicago Consortium for Advanced Science and Engineering (CASE). His research interests are at the intersection of data... Read More →


Monday August 10, 2020 11:00am - 12:00pm EDT

1:00pm EDT

Life Sciences Track - Natural Language Processing, an AI technology for COVID-19 Insights
In the rapidly evolving fight against COVID-19, pharmaceutical and healthcare organizations, governments, and the broader scientific communities around the world are working to assess the impact of the virus, and quickly develop fast, accurate solutions.

To get there, researchers and teams must have access to the best, and most up to date, evidence from a broad range of data sources including scientific literature, clinical trials and other textual sources. 

Linguamatics natural language processing (NLP) technology enables fast, systematic, comprehensive insight generation from unstructured text. Sources can include scientific literature, clinical trial records, preprints, internal sources, medical records, social media and news reports. Capturing the key information from these many sources, and synthesizing it into one hub, deepens understanding for our users, which will in turn accelerate insights and outcomes. 

In this webinar, we will discuss the benefits of natural language processing for both COVID-19 insights, and touch on broader applications of this technology across pharma and healthcare.

Speakers
avatar for Jane Reed

Jane Reed

Director, Life Sciences, Linguamatics, an IQVIA Company
Jane Reed is Director, Life Sciences, at Linguamatics, an IQVIA company. She is responsible for developing and leading the strategic vision for Linguamatics’ product portfolio and business development for the pharma and biotech market. Jane has 20+ years’ experience in vendor... Read More →


Monday August 10, 2020 1:00pm - 1:30pm EDT
 
Tuesday, August 11
 

10:00am EDT

10:05am EDT

Keynote: Plug and Play AI - Embedding Cutting Edge AI into Business Processes and Applications
Speakers
avatar for Bindu Reddy

Bindu Reddy

CEO and Co-Founder, Abacus.AI
​​​​Bindu Reddy is the CEO and Co-Founder of Abacus.AI. Before starting Abacus.AI, she was the General Manager for AI Verticals at AWS, AI. Her organization created and launched Amazon Personalize and Amazon Forecast, the first of their kind AI services that enable organizations... Read More →


Tuesday August 11, 2020 10:05am - 10:30am EDT
TBA

11:00am EDT

Life Sciences Track - From Chatbots to Predictive Analytics, How Pharma Marketers Can Leverage AI to Build Patient Connections
Decades marketing to physicians has sharpened pharma and agency skills when it comes to doctors, but what about connecting with patients? Effectively reaching and messaging patients—especially those accustomed to dealing with sophisticated consumer marketing companies like Nike and Apple—is easier said than done. That’s where artificial intelligence is making strides. Pharma marketers and their agencies are increasingly adopting AI tools such as chatbots, Alexa voice-activated health skills, natural language processing in call centers and predictive analytics for audience targeting. The result? Better health outcomes for people and a true patient-centered focus for pharma. We’ll discuss the different types of AI tools that pharma marketers and agencies are using with real world examples that highlight both the challenges and opportunities today—and in the future.

Moderators
avatar for Beth Snyder Bulik

Beth Snyder Bulik

Contributing Writer, Fierce Biotech
Beth Snyder Bulik writes for FiercePharmaMarketing. She has been a freelance journalist for 12 years, contributing to publications including Advertising Age, American Way and American Baby. Before that, she was a senior writer at Business 2.0, and held reporting positions at Advertising... Read More →

Speakers
avatar for Amy West

Amy West

Head of U.S. Digital Strategy, Novo Nordisk
avatar for Brendan Gallagher

Brendan Gallagher

Publicis Health, Chief Connected Health Officer
Brendan leads product & service design, social content, technology, and user experience capabilities across Publicis Health for major pharmaceutical, healthcare, and biotech clients. These capabilities come together seamlessly to help his clients transform, innovate, and partner better... Read More →


Tuesday August 11, 2020 11:00am - 12:00pm EDT

1:00pm EDT

Life Sciences Track - Patient insights from Social Media Listening
Patient-focused drug development requires a strong integration of the patient’s voice at every step of the drug development process. Developing clinical endpoints that are meaningful to patients and that are qualified to measure a relevant change in quality of life is challenging. The patient’s perspective is traditionally investigated with scientific literature reviews, exchange with clinical experts and patient organizations, as well as interviews with patients. However, all of these methods suffer from shortcomings such as underrepresenting the direct view of the patients or representing the view of a limited number of them.

We addressed these shortcomings by using Social Media Listening (SML) as an abundant information source to complement insights from traditional methods. Patients share their perspective not just with their clinicians, but also on social media. They talk about their symptoms and the impacts these symptoms have on their daily lives. SML strengthens the patient-centricity of the drug development process. The level of burden to the patients is significantly lower than in concept-elicitation interviews and it can reach more patients.

Social media data are highly diverse and the analysis of these data comes with significant challenges. One example is the understanding of the patient’s language and its mapping to scientific language. Given the growing amount of data available in social media, robust computational approaches have to be developed to produce meaningful insights.

This webinar will highlight how we integrate the patient’s voice via social media listening studies into the early part of the drug development process. We will give insights into the tasks and tools required for social media listening and how artificial intelligence and natural language processing can help to translate the patients’ voice into actionable insights.

Speakers
avatar for Mathias Leddin

Mathias Leddin

Senior Data Scientist, Roche
Mathias Leddin is a Senior Data Scientist at Roche pRED in Basel. He holds a Ph.D. from Humboldt-Universität zu Berlin for his work at the Max Delbrück Center for Molecular Medicine in hematopoietic cell regulation. Within the Data Science group at pRED he is specialized... Read More →


Tuesday August 11, 2020 1:00pm - 1:30pm EDT
 
Wednesday, August 12
 

10:00am EDT

10:05am EDT

Keynote: AI-Celerating R&D - Value and Impact in a Time of Convergence
While investment across the biopharma industry in R&D has been consistent or increased over the past 15 years, productivity has remained largely unchanged. Even with the projection that knowledge of medicine is doubling every 18 months, there must be better ways to understand biology and pathobiology and better ways to treat disease and manage healthcare.

Convergence, the result of the sharing of methods and ideas across multiple fields and industries, is the integration of insights and approaches from historically distinct scientific and technological disciplines. At AbbVie, our Convergence initiative seeks to create integrated R&D data and analytics capabilities that power data-driven insights – leading to better, faster decisions and therapies for patients. We are building a foundation for change, and setting out to double R&D productivity.

While hype alarms go off any time someone mentions Artificial Intelligence or ‘AI’, there are boundless opportunities to redefine AI – to engage it as the power of Automation and Insights – and drive value and impact in R&D. Tune in to this keynote to learn how AbbVie data scientists are helping our researchers scale the ladder of inference, how they are helping build foundations for growth and new capabilities, and how they are freeing up our people to perform higher value tasks. Ultimately guided by human empathy and experience, this will drive an increased ability to make a remarkable impact in the lives of patients.

Speakers
avatar for Brian Martin

Brian Martin

Head of AI, Research Fellow, AbbVie
Brian joined AbbVie in 2018 as head of a newly formed AI team, focused on accelerating, scaling, and amplifying the work of AbbVie’s R&D community using technologies like machine learning, deep learning, and cognitive computing. Prior to joining AbbVie, Brian spent five years consulting... Read More →


Wednesday August 12, 2020 10:05am - 10:30am EDT
TBA

11:00am EDT

Life Sciences Track - Putting AI To The Test In Clinical Trials
Drugmakers have been working for years to streamline clinical trials, the costly, time-consuming tests required to bring all new drugs and vaccines to market. Enter AI, which can match patients to appropriate trials, manage workflow, analyze incoming data, and help keep participants on track with treatment. These tools can not only save time and money—and flag any problems early—but also increase the chances of success in the clinic. We’ll examine today’s AI tools, discuss how they’re used in the field and find out what’s coming next.

Moderators
avatar for Amirah Al Idrus

Amirah Al Idrus

Editor, Fierce Biotech
Amirah Al Idrus is an editor with the Life Sciences group covering biotech, medtech and occasionally, biotech research. She started her career at The Center for Public Integrity, where she was on a team that earned an Al Neuharth Innovation in Investigative Award for their work covering how companies profit from the privatization of prisons. When she’s not working, Amirah spends her time playing rugby, trying to keep her plants alive and baking (and eating) pies... Read More →

Speakers
avatar for Najat Khan, Ph.D.

Najat Khan, Ph.D.

Chief Data Science Officer and Global Head of Strategy and Operations, Janssen R&D
avatar for Dr. Raolat Abdulai

Dr. Raolat Abdulai

Clinical Research Director, Sanofi
Dr. Abdulai is the clinical research director for Immunology and Inflammation (I&I) at Sanofi and acts to advance the digital health strategy within I&I which includes advancing technology in R&D that transforms the product life cycle for faster and more efficient clinical trials... Read More →
avatar for James Hamrick

James Hamrick

Senior Medical Director, Flatiron
James Hamrick is currently senior medical director at Flatiron Health, where he is responsible for overseeing the clinical development of the OncoTrials® and research software products as well as providing clinical insight in the development of new features in OncoEMR®. James... Read More →
avatar for Alok Tayi, Ph.D.

Alok Tayi, Ph.D.

Vice President of Life Sciences, Egnyte
Alok is the Vice President of Life Sciences at Egnyte where he is responsible for building and executing the company's strategy for the life sciences market segment. Prior to his career in software, Alok spent over 15 years as a scientist: he took part in postdoctoral work at Harvard... Read More →
avatar for Ajay Royyuru, Ph.D.

Ajay Royyuru, Ph.D.

IBM Fellow and Vice President, Healthcare and Life Sciences, IBM
Ajay Royyuru leads Healthcare & Life Sciences research at IBM. His team is actively pursuing high quality science, developing novel technologies and achieving translational insights across this industry, including areas of cancer, cardiac, neurological, mental health, immune s... Read More →


Wednesday August 12, 2020 11:00am - 12:00pm EDT

1:00pm EDT

Life Sciences Track - Using AI to Predict the Outcome of Clinical Trials
The outcome of a clinical trial is the deciding factor for the future success of a biotechnology and pharmaceutical company. It is therefore important that every critical parameter for a clinical trial is taken into consideration to ensure the highest possible chance of a positive outcome. Using AI and an advanced analytics-enabled engine Innoplexus made it possible to calculate, understand, and predict the outcome of future and ongoing clinical trials using real-world, outside-trial, and biomedical data sets. Hence, enabling companies to choose the best set of parameters for their clinical study. 

Speakers
avatar for Dr. Gunjan Bhardwaj

Dr. Gunjan Bhardwaj

Founder and CEO, Innoplexus AG
Dr. Gunjan Bhardwaj is the founder and CEO of the Innoplexus AG, a leading global AI champion in the field of drug discovery & development. Gunjan was earlier with the Boston Consulting Group and before that the leader of the global business performance think-tank of Ernst & Young... Read More →


Wednesday August 12, 2020 1:00pm - 1:30pm EDT